De Luca A, Tosolini A, Russo P, Severino A, Baldi A, De Luca L, Cavallotti I, Baldi F, Giordano A, Testa J R, Paggi M G
Laboratory of Cell Metabolism and Pharmacokinetics, CRS, Regina Elena Cancer Institute, Rome, Italy.
J Histochem Cytochem. 2001 Jun;49(6):693-8. doi: 10.1177/002215540104900603.
Cyclin T2a was recently identified as one of the regulatory subunits of the cdk-cyclin complex P-TEFb, the most studied positive factor in the regulation of transcription elongation. By fluorescent in situ hybridization (FISH), the gene codifying for cyclin T2a has been mapped on human chromosome 2q21. This locus also has been linked to different forms of myopathy. By use of a new specific antiserum raised against cyclin T2a, the immunohistochemical pattern of expression of cyclin T2a in human tissues has been examined and compared to that of cyclin T1, described in the previous report. The observation that immunohistochemical expression of cyclin T2a was high in skeletal muscle cells, whereas it was undetectable in two cases of centronuclear myopathy, together with its chromosomal location, suggests an involvement of the cdk9-cyclin T2a complex in this disease.
细胞周期蛋白T2a最近被鉴定为细胞周期蛋白依赖性激酶-细胞周期蛋白复合物P-TEFb的调节亚基之一,P-TEFb是转录延伸调控中研究最多的正性因子。通过荧光原位杂交(FISH),编码细胞周期蛋白T2a的基因已定位到人类染色体2q21上。该基因座也与不同形式的肌病有关。通过使用针对细胞周期蛋白T2a产生的一种新的特异性抗血清,研究了细胞周期蛋白T2a在人体组织中的免疫组织化学表达模式,并与先前报告中描述的细胞周期蛋白T1的表达模式进行了比较。细胞周期蛋白T2a在骨骼肌细胞中的免疫组织化学表达较高,而在两例中央核性肌病中未检测到,再加上其染色体定位,提示cdk9-细胞周期蛋白T2a复合物参与了这种疾病。